Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study
Titel:
Improvements in functioning and workplace productivity with esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression: Findings from a 32-week randomised, open-label, rater-blinded phase IIIb study
Auteur:
Vieta, Eduard Ahmed, Nahida Arango, Celso Cleare, Anthony J. Demyttenaere, Koen Dold, Markus Ito, Tetsuro Kambarov, Yerkebulan Krüger, Stephanie Llorca, Pierre-Michel McIntyre, Roger S. Sani, Gabriele von Holt, Christian Rive, Benoit